Cargando…

PB1740: THE COMBINATION OF PONATINIB PLUS CHEMOTHERAPY UPFRONT ACHIEVES DURABLE COMPLETE MOLECULAR REMISSIONS IN ADULTS PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA.

Detalles Bibliográficos
Autores principales: Sotirios, Papageorgiou, Bouchla, Anthi, Gkontopoulos, Konstantinos, Thomopoulos, Thomas, Loukari, Constantinos, Apostolopoulou, Christina, Vryttia, Pinelopi, Zormpa, Artemis, Tsakatikas, Sergios, Pappa, Vasiliki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429966/
http://dx.doi.org/10.1097/01.HS9.0000973820.33926.c2
_version_ 1785090842883522560
author Sotirios, Papageorgiou
Bouchla, Anthi
Gkontopoulos, Konstantinos
Thomopoulos, Thomas
Loukari, Constantinos
Apostolopoulou, Christina
Vryttia, Pinelopi
Zormpa, Artemis
Tsakatikas, Sergios
Pappa, Vasiliki
author_facet Sotirios, Papageorgiou
Bouchla, Anthi
Gkontopoulos, Konstantinos
Thomopoulos, Thomas
Loukari, Constantinos
Apostolopoulou, Christina
Vryttia, Pinelopi
Zormpa, Artemis
Tsakatikas, Sergios
Pappa, Vasiliki
author_sort Sotirios, Papageorgiou
collection PubMed
description
format Online
Article
Text
id pubmed-10429966
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104299662023-08-17 PB1740: THE COMBINATION OF PONATINIB PLUS CHEMOTHERAPY UPFRONT ACHIEVES DURABLE COMPLETE MOLECULAR REMISSIONS IN ADULTS PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA. Sotirios, Papageorgiou Bouchla, Anthi Gkontopoulos, Konstantinos Thomopoulos, Thomas Loukari, Constantinos Apostolopoulou, Christina Vryttia, Pinelopi Zormpa, Artemis Tsakatikas, Sergios Pappa, Vasiliki Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429966/ http://dx.doi.org/10.1097/01.HS9.0000973820.33926.c2 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Sotirios, Papageorgiou
Bouchla, Anthi
Gkontopoulos, Konstantinos
Thomopoulos, Thomas
Loukari, Constantinos
Apostolopoulou, Christina
Vryttia, Pinelopi
Zormpa, Artemis
Tsakatikas, Sergios
Pappa, Vasiliki
PB1740: THE COMBINATION OF PONATINIB PLUS CHEMOTHERAPY UPFRONT ACHIEVES DURABLE COMPLETE MOLECULAR REMISSIONS IN ADULTS PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA.
title PB1740: THE COMBINATION OF PONATINIB PLUS CHEMOTHERAPY UPFRONT ACHIEVES DURABLE COMPLETE MOLECULAR REMISSIONS IN ADULTS PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA.
title_full PB1740: THE COMBINATION OF PONATINIB PLUS CHEMOTHERAPY UPFRONT ACHIEVES DURABLE COMPLETE MOLECULAR REMISSIONS IN ADULTS PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA.
title_fullStr PB1740: THE COMBINATION OF PONATINIB PLUS CHEMOTHERAPY UPFRONT ACHIEVES DURABLE COMPLETE MOLECULAR REMISSIONS IN ADULTS PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA.
title_full_unstemmed PB1740: THE COMBINATION OF PONATINIB PLUS CHEMOTHERAPY UPFRONT ACHIEVES DURABLE COMPLETE MOLECULAR REMISSIONS IN ADULTS PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA.
title_short PB1740: THE COMBINATION OF PONATINIB PLUS CHEMOTHERAPY UPFRONT ACHIEVES DURABLE COMPLETE MOLECULAR REMISSIONS IN ADULTS PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA.
title_sort pb1740: the combination of ponatinib plus chemotherapy upfront achieves durable complete molecular remissions in adults patients with philadelphia chromosome-positive (ph+) acute lymphoblastic leukemia.
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429966/
http://dx.doi.org/10.1097/01.HS9.0000973820.33926.c2
work_keys_str_mv AT sotiriospapageorgiou pb1740thecombinationofponatinibpluschemotherapyupfrontachievesdurablecompletemolecularremissionsinadultspatientswithphiladelphiachromosomepositivephacutelymphoblasticleukemia
AT bouchlaanthi pb1740thecombinationofponatinibpluschemotherapyupfrontachievesdurablecompletemolecularremissionsinadultspatientswithphiladelphiachromosomepositivephacutelymphoblasticleukemia
AT gkontopouloskonstantinos pb1740thecombinationofponatinibpluschemotherapyupfrontachievesdurablecompletemolecularremissionsinadultspatientswithphiladelphiachromosomepositivephacutelymphoblasticleukemia
AT thomopoulosthomas pb1740thecombinationofponatinibpluschemotherapyupfrontachievesdurablecompletemolecularremissionsinadultspatientswithphiladelphiachromosomepositivephacutelymphoblasticleukemia
AT loukariconstantinos pb1740thecombinationofponatinibpluschemotherapyupfrontachievesdurablecompletemolecularremissionsinadultspatientswithphiladelphiachromosomepositivephacutelymphoblasticleukemia
AT apostolopoulouchristina pb1740thecombinationofponatinibpluschemotherapyupfrontachievesdurablecompletemolecularremissionsinadultspatientswithphiladelphiachromosomepositivephacutelymphoblasticleukemia
AT vryttiapinelopi pb1740thecombinationofponatinibpluschemotherapyupfrontachievesdurablecompletemolecularremissionsinadultspatientswithphiladelphiachromosomepositivephacutelymphoblasticleukemia
AT zormpaartemis pb1740thecombinationofponatinibpluschemotherapyupfrontachievesdurablecompletemolecularremissionsinadultspatientswithphiladelphiachromosomepositivephacutelymphoblasticleukemia
AT tsakatikassergios pb1740thecombinationofponatinibpluschemotherapyupfrontachievesdurablecompletemolecularremissionsinadultspatientswithphiladelphiachromosomepositivephacutelymphoblasticleukemia
AT pappavasiliki pb1740thecombinationofponatinibpluschemotherapyupfrontachievesdurablecompletemolecularremissionsinadultspatientswithphiladelphiachromosomepositivephacutelymphoblasticleukemia